Fussbroich et al. investigated the expression of EZH2 in colon cancer and adenomas immunohistochemically and reported a significant increase in EZH2 expression in CRC, especially in less differentiated carcinomas (Fussbroich et al. 2011). Here, EZH2 is linked to colorectal carcinoma.